GeneOne Life Science

GeneOne Life Science News

FDA approves first in-human study of MERS vaccine

A new Middle East Respiratory Syndrome (MERS) vaccine developed by GeneOne Life Science Inc. and Inovio Pharmaceuticals has received approval from the Food and Drug Administration to begin its first in-human clinical study. Read More »

Army enters partnership to create MERS vaccine

GeneOne Life Science and the Walter Reed Army Institute of Research (WRAIR) recently developed a partnership to create a vaccine to protect people from Middle East respiratory syndrome (MERS). Read More »